|
|
Volumn 21, Issue 5, 1995, Pages 1322-1336
|
|
Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double-blind, placebo-controlled, multicenter trial
a
a
a
b
b
c
d
e
f
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATOSSISCLEROL;
FIBRIN;
OCTREOTIDE;
POLIDOCANOL;
SOMATOSTATIN;
TERLIPRESSIN;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
ENDOSCOPY;
ESOPHAGUS VARICES BLEEDING;
FEMALE;
HUMAN;
HYPEREMIA;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER CIRRHOSIS;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTICENTER STUDY;
PORTAL VEIN BLOOD PRESSURE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCLEROTHERAPY;
SUBCUTANEOUS DRUG ADMINISTRATION;
AGED;
DOUBLE-BLIND METHOD;
ESOPHAGEAL AND GASTRIC VARICES;
ESOPHAGEAL DISEASES;
FEMALE;
HEMORRHAGE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
MALE;
MIDDLE AGED;
OCTREOTIDE;
PLACEBOS;
RECURRENCE;
SCLEROTHERAPY;
SURVIVAL ANALYSIS;
|
|
EID: 0029061061
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1016/0270-9139(95)90054-3 Document Type: Article |
|
Times cited : (65)
|
|
References (22)
|
